Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2026-02-25 @ 8:11 PM
Study NCT ID:
NCT02276560
Status:
TERMINATED
Last Update Posted:
2017-05-11
First Post:
2014-10-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC
Sponsor:
UNC Lineberger Comprehensive Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01
Start Date Type:
None
Primary Completion Date:
2016-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-06
Completion Date Type:
ACTUAL
First Submit Date:
2014-10-21
First Submit QC Date:
None
Study First Post Date:
2014-10-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-03-29
Results First Submit QC Date:
None
Results First Post Date:
2017-05-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-03-29
Last Update Post Date:
2017-05-11
Last Update Post Date Type:
ACTUAL